J. Judice
Chief Executive Officer at DICE THER
J. Judice active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DICE THER | Founder | - | - |
| Chief Executive Officer | 31/07/2013 | - | |
| Director/Board Member | - | - | |
DiCE Molecules, Inc.
 DiCE Molecules, Inc. Packaged SoftwareTechnology Services DiCE Molecules, Inc. is a private company that focuses on immunology and small molecule discovery. The company is based in Menlo Park, CA. The company's goal is to provide convenient oral medicines with biologic-like efficacy to patients with chronic diseases. The company was founded by J. Kevin Judice and he has been the CEO since incorporation. | Chief Executive Officer | - | - |
| Founder | - | - | |
| President | - | - | |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Chief Executive Officer | 31/12/2012 | - |
| Founder | 31/12/2012 | - |
Career history of J. Judice
Former positions of J. Judice
| Companies | Position | Start | End |
|---|---|---|---|
| CIDARA THERAPEUTICS, INC. | Director/Board Member | 29/06/2014 | 19/04/2015 |
| Chief Tech/Sci/R&D Officer | 29/06/2014 | - | |
| Founder | 30/11/2012 | 19/04/2015 | |
| ACHAOGEN | Director/Board Member | 18/01/2011 | 30/09/2011 |
| Chief Executive Officer | 31/05/2002 | 30/09/2011 | |
| Chief Tech/Sci/R&D Officer | 31/05/2002 | 30/09/2011 | |
| Founder | 31/05/2002 | 06/03/2011 | |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 31/08/1997 | 28/02/2002 |
| INNOVIVA, INC. | Corporate Officer/Principal | - | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Training of J. Judice
| Texas A&M University | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Statistics
International
| United States | 11 |
Operational
| Founder | 5 |
| Chief Executive Officer | 4 |
| Director/Board Member | 3 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| CIDARA THERAPEUTICS, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
DiCE Molecules, Inc.
DiCE Molecules, Inc. Packaged SoftwareTechnology Services DiCE Molecules, Inc. is a private company that focuses on immunology and small molecule discovery. The company is based in Menlo Park, CA. The company's goal is to provide convenient oral medicines with biologic-like efficacy to patients with chronic diseases. The company was founded by J. Kevin Judice and he has been the CEO since incorporation. | Technology Services |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Finance |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- J. Judice
- Experience
